Skip to main content
Premium Trial:

Request an Annual Quote

Fugent FuGene SI Transfection Reagent

Fugent has released its first transfection reagent for the delivery of RNA molecules. The new FuGene SI Transfection Reagent was engineered to provide researchers more efficient delivery of siRNA, miRNA, and other similar short RNAs into human and animal cells, the company said. The novel, multi-component transfection reagent allows researchers to obtain robust gene silencing while utilizing low amounts of siRNA and reagent. Key applications of the new reagent include gene silencing, siRNA library screens, miRNA delivery, and short RNA delivery, Fugent said.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.